Disease heterogeneity in amyotrophic lateral sclerosis poses a substantial challenge in drug
development. Categorization based on clinical features alone can help us predict the …

This manuscript is the second part of a two-part description of the current status of
understanding of the network function of the brain in health and disease. We start with the …

Cognitive dysfunction is an important non-motor symptom in amyotrophic lateral sclerosis
(ALS) that has a negative impact on survival and caregiver burden. It shows a wide spectrum …

Performance deficits on the Wisconsin Card Sorting Test (WCST) in patients with prefrontal
cortex (PFC) lesions are traditionally interpreted as evidence for a role of the PFC in …

Advances in neuroimaging, complementing histopathological insights, have established a
multi-system involvement of cerebral networks beyond the traditional neuromuscular …

This work presents the design, implementation, and evaluation of a P300-based brain-
machine interface (BMI) developed to control a robotic hand-orthosis. The purpose of this …

Objective We investigated whether cognitive reserve measured by education and premorbid
IQ allows amyotrophic lateral sclerosis patients to compensate for regional brain volume …

The clinical neuropsychologist has the opportunity to be uniquely involved in the evaluation
and treatment of individuals with amyotrophic lateral sclerosis (ALS). We review the current …

Monitoring one's actions is essential for goal-directed performance. In the event-related
potential (ERP), errors are followed by fronto-centrally distributed negativities. These error …

Characteristics of Severe and Enduring Anorexia Nervosa (SE-AN) are being investigated to
differentiate the patients experiencing SE-AN from those at earlier stages of the AN disease …